How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines variants in related metabolic genes (FTO, MC4R, GIPR) that may help provide context for how your body's appetite and weight-regulation pathways respond to GLP-1 signaling
While many GLP-1 drugs are currently covered by Medicare Part D and Medicaid when prescribed for certain conditions, such as type 2 diabetes, Medicare has been prohibited from covering the drugs solely for weight loss, and only 16 state Medicaid programs, not including Arkansas, cover GLP-1 therapies for obesity treatment
Beasley enjoys cooking, reading, and trips to the beach with his wife and two kids (with sunscreen of course).
Sweeting A, Hannah W, Backman H, Catalano P, Feghali M, Herman WH
Extended-release forms may be easier for some people, although suitability varies